Pharmacology D441 2026/2027 | 200+ Questions & Answers | CNS Drugs, Antiepileptics, Parkinson’s, Psychopharmacology & Substance Use

The Pharmacology D441 2026/2027 document is a comprehensive 59-page pharmacology exam-preparation resource containing 200+ questions, answers, medication profiles, mechanisms of action, adverse effects, contraindications, drug interactions, antidotes, and nursing considerations. Key areas include medication administration and drug reconstitution, pediatric dosage calculations, CNS depressants and stimulants, sedative-hypnotics, muscle relaxants, antiepileptic medications, Parkinson’s disease pharmacotherapy, anxiolytics, mood stabilizers, antidepressants, antipsychotics, substance-use pharmacology, opioids, and adrenergic drugs. The material is organized around high-yield medication facts and clinical nursing considerations that support recognition of drug classes, therapeutic uses, toxicity, monitoring requirements, and safe administration. The opening section addresses safe medication administration and dosage calculations. Drug reconstitution is explained as adding a liquid solvent to a powdered medication, with attention to selecting the prescribed diluent, mixing the medication, and distinguishing single-dose from multidose preparations. Pediatric pharmacology covers weight-based dosing, conversion from pounds to kilograms, gram-to-kilogram conversions, calculation of minimum and maximum safe dose ranges, and the importance of accurate measurement when pediatric doses are less than 1 mL. The resource also introduces magnesium sulfate in obstetric nursing and transitions into CNS pharmacology. A substantial section covers CNS depressants, benzodiazepines, nonbenzodiazepine hypnotics, barbiturates, and centrally acting muscle relaxants. Medications discussed include diazepam, midazolam, lorazepam, clonazepam, temazepam, eszopiclone, ramelteon, zolpidem, pentobarbital, phenobarbital, baclofen, cyclobenzaprine, and carisoprodol. Students review GABA-related mechanisms, sedation, anxiety relief, sleep induction, moderate sedation, respiratory depression, fall risk, drug interactions, contraindications, withdrawal concerns, and flumazenil as the benzodiazepine reversal agent. Nursing assessment before sedative-hypnotic therapy includes vital signs, respiratory status, alertness, alcohol and medication history, and potential renal and hepatic function testing. The CNS stimulant and antiepileptic sections cover amphetamines, methylphenidate, hydantoins, succinimides, iminostilbenes, barbiturates, and miscellaneous anticonvulsants. Specific drugs include phenytoin, fosphenytoin, ethosuximide, carbamazepine, oxcarbazepine, gabapentin, lamotrigine, levetiracetam, pregabalin, tiagabine, topiramate, valproic acid, and zonisamide. High-yield adverse effects include gingival hyperplasia with phenytoin, aplastic anemia and bone-marrow suppression with carbamazepine, hepatotoxicity concerns with valproic acid, and CNS effects associated with antiepileptic therapy. The guide emphasizes seizure assessment, baseline neurologic function, CBC, renal and hepatic studies, medication history, and monitoring for adverse reactions. A major portion is devoted to Parkinson’s disease pharmacology. The resource organizes treatment into MAO-B inhibitors, dopamine modulators, COMT inhibitors, direct dopamine agonists, dopamine replacement therapy, anticholinergics, and antihistamines. Drugs reviewed include rasagiline, selegiline, amantadine, entacapone, tolcapone, bromocriptine, pramipexole, ropinirole, rotigotine, levodopa-carbidopa, benztropine, trihexyphenidyl, and diphenhydramine. Students review the dopamine-acetylcholine relationship and the TRAP features—tremor, rigidity, akinesia, and postural instability—as presented in the document. The Parkinson’s material also emphasizes clinically important drug-food interactions and adverse effects. MAO-B inhibitors are discussed alongside tyramine-containing foods and potentially interacting serotonergic or opioid medications. COMT inhibitors are connected with prolonged levodopa activity and reduction of the “wearing-off” effect, while tolcapone is highlighted for serious hepatotoxicity. Levodopa-carbidopa content includes dyskinesias, hypotension, GI effects, cardiac dysrhythmias, vitamin B6 and dietary protein considerations. Benztropine and related anticholinergic therapy are associated with dry mouth, blurred vision, constipation, urinary retention, and particular caution in older adults. The psychopharmacology section reviews medications for anxiety, mood disorders, and depression. Benzodiazepines such as alprazolam, diazepam, and lorazepam, along with buspirone, are examined for their indications, adverse effects, interactions, dependency potential, and nursing implications. The resource also covers lithium, emphasizing its narrow therapeutic range and increased toxicity risk with dehydration, sodium imbalance, renal impairment, thiazide diuretics, ACE inhibitors, and NSAIDs. Antidepressant pharmacology includes tricyclic antidepressants (TCAs), monoamine oxidase inhibitors (MAOIs), SSRIs, SNRIs, bupropion, trazodone, and St. John’s wort. Students review amitriptyline, isocarboxazid, phenelzine, tranylcypromine, selegiline, citalopram, escitalopram, fluoxetine, sertraline, duloxetine, venlafaxine, desvenlafaxine, and bupropion. High-yield concepts include anticholinergic effects and potentially severe TCA overdose, tyramine-associated hypertensive crisis with MAOIs, sexual dysfunction and other SSRI adverse effects, bupropion’s seizure-threshold considerations, and serotonin syndrome manifestations including agitation, tachycardia, sweating, muscle spasms, hyperthermia, seizures, and renal complications. The later section examines antipsychotic medications and serious adverse reactions. The document describes dopamine-receptor blockade and reviews drugs such as chlorpromazine, perphenazine, thioridazine, and haloperidol. Important adverse effects covered include extrapyramidal symptoms, tardive dyskinesia, neuroleptic malignant syndrome, neutropenia, agranulocytosis, hemolytic anemia, insulin resistance, weight gain, lipid abnormalities, and metabolic syndrome. The material additionally emphasizes medication-related warnings and cautions surrounding older adults, pregnancy, CNS depression, organ impairment, epilepsy, and abrupt medication discontinuation. The final pages focus on substance-use pharmacology, opioids, withdrawal management, stimulants, and adrenergic drugs. Students review opioid receptor activity, analgesia and euphoria, respiratory depression, miosis, constipation, urinary retention, hypotension, and naloxone as an opioid antagonist used for overdose reversal. Opioid withdrawal content includes mydriasis, piloerection, diaphoresis, rhinorrhea, lacrimation, vomiting, diarrhea, anxiety, muscle cramps, and increased blood pressure and pulse, with clonidine, methadone, and relapse-prevention concepts discussed in the document. Stimulants such as amphetamine, cocaine, methamphetamine, dextroamphetamine, methylphenidate, and MDMA are followed by an introduction to adrenergic/sympathomimetic pharmacology and alpha-1 and beta-1 receptor activity. Relevant students: This resource is particularly relevant for Pharmacology D441 students, nursing pharmacology students, prelicensure nursing students, BSN students, RN-to-BSN students, nursing fundamentals students, psychiatric nursing students, neuroscience pharmacology students, and NCLEX-RN candidates reviewing medication administration, neurologic and psychiatric drugs, adverse effects, contraindications, drug interactions, antidotes, and nursing monitoring. The uploaded document does not identify a university or college, so no institution has been added to avoid unsupported attribution. Keywords: Pharmacology D441 2026, Pharmacology D441 2027, D441 pharmacology questions and answers, D441 pharmacology study guide, pharmacology exam questions, nursing pharmacology exam, medication administration nursing, drug reconstitution, pediatric dosage calculations, CNS depressants, CNS stimulants, benzodiazepines nursing, flumazenil antidote, zolpidem pharmacology, barbiturates pharmacology, muscle relaxants nursing, baclofen pharmacology, cyclobenzaprine pharmacology, antiepileptic drugs, anticonvulsant pharmacology, phenytoin nursing, gingival hyperplasia, carbamazepine pharmacology, valproic acid nursing, Parkinson disease medications, levodopa carbidopa, benztropine nursing, MAO B inhibitors, COMT inhibitors, dopamine agonists, psychopharmacology nursing, anxiolytic medications, alprazolam pharmacology, lorazepam nursing, buspirone pharmacology, lithium toxicity, antidepressant pharmacology, tricyclic antidepressants, MAOI pharmacology, SSRI pharmacology, SNRI pharmacology, serotonin syndrome, bupropion pharmacology, St Johns wort interactions, antipsychotic medications, extrapyramidal symptoms, tardive dyskinesia, neuroleptic malignant syndrome, substance use disorder pharmacology, opioid pharmacology, naloxone antidote, opioid withdrawal, clonidine withdrawal, methadone pharmacology, adrenergic drugs, sympathomimetic drugs, NCLEX pharmacology review